BUZZ-U.S. STOCKS ON THE MOVE-Tracon, OHR Pharma, Graftech, Doral

Mon Mar 2, 2015 1:15pm EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter,

The Nasdaq Composite index hit the 5,000 mark on Monday for the first time since March 27, 2000 and edged closer to its 5,132.52 all-time peak it reached that same month in the frenzy of the dot-come bubble. The Dow Jones industrial average was up 0.59 percent at 18,240.33, the S&P 500 was up 0.33 percent at 2,111.37 and the Nasdaq Composite was up 0.47 percent at 4,986.878.

** TRACON PHARMACEUTICALS INC, $19.28, +43.56 pct

Stifel Nicolaus raised price target on the drug developer's stock to $20 from $16. Company said on Friday that its experimental cancer drug was effective in improving overall survival in patients with advanced renal cell carcinoma, a type of kidney cancer, in an early-stage study.

** OHR PHARMACEUTICAL INC, $10.4, +35.24 pct

The eye drug developer said the mid-stage study of its squalamine eye drops improved vision by week 4 in patients with a wet form of age-related blindness, when used in combination with lucentis. Cowen and Co initiated coverage of the stock with an "outperform" rating and price target of $25.

** GRAFTECH INTERNATIONAL LTD, $4.63, +18.72 pct   Continued...